Bayesian Capital Management, LP Ardelyx, Inc. Transaction History

Bayesian Capital Management, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$6.05 - $9.74 $544,796 - $877,077	90,049 New	90,049 $657,000
Q3 2023 Nov 14, 2023	BUY	$3.3 - $4.83 $212,520 - $311,052	64,400 Added 202.84%	96,149 $392,000
Q2 2023 Aug 14, 2023	SELL	$3.23 - $4.95 $397,613 - $609,345	-123,100 Reduced 79.5%	31,749 $107,000
Q1 2023 May 15, 2023	BUY	$2.68 - $4.79 $370,239 - $661,733	138,149 Added 827.24%	154,849 $741,000
Q4 2022 Feb 14, 2023	BUY	$1.22 - $2.85 $20,374 - $47,595	16,700 New	16,700 $47,000

219

141M

1.08M

Ticker ARDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 154,636,000
Market Cap $815M
Description
Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...

Get notified when there are updates to the investment portfolio of Bayesian Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Bayesian Capital Management, LP with notifications on news.